Application 216167
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPIRAMATE | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216167-001 | TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | 2023-02-09 | 053a50430f4f… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216167-001 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | 2023-02-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216167-001 | AB1 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216167-001 | AB1 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216167-001 | AB1 | 1 | 053a50430f4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | 3f99b26b-79b9-4efb-aa2c-2868e1e126c8 | 2026-11-06 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | A-S Medication Solutions | f7f2d1bc-9c65-4798-826f-6902b3ec81dc | 2026-10-13 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | A-S Medication Solutions | 88156c4e-bc29-497d-8110-e59d800ff38a | 2026-10-13 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | 610d4df7-703f-4070-9adc-3e57ca05a2f1 | 2026-10-08 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 5424d59e-74f1-4c3c-b737-79e9776e0b60 | 2026-10-08 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals Inc. | 83558f89-1adb-4d81-b19b-68721d48034b | 2026-10-07 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals, Inc. | 2b6b0642-fb91-4641-9c51-d3be2021992b | 2026-10-07 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals Inc. | be42ed09-350c-4e8a-aff4-6afb242dd599 | 2026-10-07 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Cardinal Health 107, LLC | e5bc696e-040d-4d3e-b38c-9548a38fa936 | 2026-10-06 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | be14624b-7eb9-4e7a-9274-1bb88270ecbe | 2026-10-06 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Preferred Pharmaceuticals, Inc. | d8454fdf-7b34-49c0-b130-732e39b774b2 | 2026-10-06 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Trokendi XR | TOPIRAMATE | Supernus Pharmaceuticals, Inc. | 2dc7957e-a3e5-46bb-aa66-f3250f872f5e | 2026-10-05 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 149d20de-f262-4567-aa97-d4d28a1653cb | 2026-09-29 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Cranbury Pharmaceuticals, LLC | 8d5f9f77-403e-432a-8dcb-7995c6947ae0 | 2026-09-29 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | NorthStar RxLLC | b5f8da43-6daf-413c-9dcd-363617973738 | 2026-09-23 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| topiramate | TOPIRAMATE | St. Mary's Medical Park Pharmacy | 5bb06bfe-3536-c619-e063-6294a90a1a61 | 2026-09-17 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | St. Mary's Medical Park Pharmacy | 46a305cb-ab73-0bca-e063-6294a90a9b85 | 2026-09-15 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| QUDEXY XR | TOPIRAMATE | Upsher-Smith Laboratories, LLC | 46f54677-3a22-4c38-9b92-923020164e15 | 2026-09-03 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Ajanta Pharma USA Inc. | 813f5fe2-df82-479c-8014-d503ff5df52b | 2026-09-03 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 0c0a6774-e234-47a5-866e-462cfd99744c | 2026-09-01 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73990 | ORIG | 2023-04-14 |